Carneiro Pedro B, Radix Asa E, Golub Sarit, Grosskopf Nicholas, Grov Christian
Department of Community Health and Social Sciences, CUNY Graduate School of Public Health and Health Policy, New York, NY.
Callen-Lorde Community Health Center, New York, NY.
J Acquir Immune Defic Syndr. 2024 Dec 1;97(4):357-363. doi: 10.1097/QAI.0000000000003492.
Efforts to improve pre-exposure prophylaxis (PrEP) uptake among gay men, transgender women, and Black cisgender women are evident across the United States, responding to epidemiologic data showing a disproportionate HIV burden in these communities. However, transgender men and other transmasculine people who have sex with men (TMSM)-those assigned female at birth who identify otherwise and have sex with cisgender men-are often excluded from these statistics. This community has unique vulnerabilities and prevention needs. National HIV prevention and planning has yet to include transgender men as a group with increased vulnerability to HIV seroconversion. This study follows a cohort of TMSM to characterize PrEP use longitudinally.
Using data from a prospective US national cohort of TMSM not on PrEP, we analyzed annual PrEP uptake, discontinuation, and other HIV prevention measures over 24 months. We also used generalized estimating equations modeling to assess demographic, healthcare access, gender-affirming, and behavioral factors associated with PrEP uptake over time.
Our cohort of 196 TMSM was demographic and regionally diverse. 29% of our sample reported uptake of PrEP in 24 months, with about one-third of users discontinuing within 1 year. Health insurance, having had lower surgery, used post-exposure prophylaxis, or recently having a sexually transmitted infection were associated with increased odds of PrEP use.
We found low uptake of PrEP and high discontinuation rates in a US national sample of TMSM over 24 months, despite significant need for HIV prevention. It is vital to increase efforts and investments to support this neglected community.
在美国,为提高男同性恋者、跨性别女性和黑人顺性别女性的暴露前预防(PrEP)使用率所做的努力显而易见,这是对显示这些群体中艾滋病毒负担不成比例的流行病学数据做出的回应。然而,跨性别男性以及其他与男性发生性行为的跨性别男性(TMSM)——那些出生时被指定为女性但有不同身份认同且与顺性别男性发生性行为的人——往往被排除在这些统计数据之外。这个群体有独特的脆弱性和预防需求。国家艾滋病毒预防和规划尚未将跨性别男性列为艾滋病毒血清转化易感性增加的群体。本研究追踪了一组TMSM,以纵向描述PrEP的使用情况。
利用来自美国一个未使用PrEP的TMSM前瞻性全国队列的数据,我们分析了24个月内的年度PrEP使用率、停药率以及其他艾滋病毒预防措施。我们还使用广义估计方程模型来评估与随时间推移PrEP使用相关的人口统计学、医疗保健可及性、性别确认和行为因素。
我们的196名TMSM队列在人口统计学和地域上具有多样性。我们样本中的29%报告在24个月内开始使用PrEP,约三分之一的使用者在1年内停药。医疗保险、接受过下体手术、使用过暴露后预防措施或近期患有性传播感染与PrEP使用几率增加有关。
我们发现,在美国一个TMSM全国样本中,尽管对艾滋病毒预防有巨大需求,但在24个月内PrEP使用率较低且停药率较高。加大努力和投资以支持这个被忽视的群体至关重要。